Frontlight ResearchEarly access
Trial site
U.T. MD Anderson Cancer Center
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer3 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Mesothelioma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 31 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Pfizer2 trials
- Fusion Pharmaceuticals Inc.1 trial
- Kartos Therapeutics, Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Recruiting
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Prostate cancer2 recruiting
- Mesothelioma1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026